Trial Profile
Phase I pilot study of INT 0036 as a potential therapy for schizophrenia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2014
Price :
$35
*
At a glance
- Drugs Loxapine (Primary) ; Loxapine
- Indications Schizophrenia
- Focus First in man; Pharmacokinetics
- 10 Nov 2014 New trial record
- 03 Nov 2014 Results published in an IntelGenx Corp. media release.